WNT1 and urinary bladder carcinoma: Our research revealed that knockdown of XIST significantly reduced expression levels of tumor-related genes (Wnt1, β-catenin and cyclin-D1) in the Wnt/β-catenin signaling pathway in bladder cancer cells.